272
Participants
Start Date
November 20, 2023
Primary Completion Date
August 5, 2024
Study Completion Date
November 30, 2024
LAU-7b for 3 cycles
Three cycles of 14 days of once-a-day intake of LAU-7b, each followed by a treatment intake pause of14 days.
LAU-7b for 1 cycle, then placebo
One cycle of 14 days of once-a-day intake of LAU-7b followed by two cycles of 14 days of placebo administered similarly, each followed by a treatment intake pause of14 days.
Placebo for 3 cycles
Three cycles of 14 days of once-a-day intake of placebo, each followed by a treatment intake pause of14 days
CIUSS du Saguenay-Lac-St-Jean - Hôpital Chicoutimi, Chicoutimi
Institut de Recherches Cliniques de Montréal, Montreal
Montreal General Hospital, Montreal
Diex Recherche Québec Inc., Québec
Centre Hospitalier de l'Université de Sherbrooke, Sherbrooke
Lead Sponsor
Laurent Pharmaceuticals Inc.
INDUSTRY